TORONTO, Dec. 30, 2021 /CNW/ – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (formerly
Colson Capital Corp.) (“Pathway” or the “Company”), an integrated healthcare company that
provides products and services to patients suffering from chronic pain and related conditions,
announces the issuance of 1,300,000 stock options to officers, employees and consultants on
December 28, 2021. Each option allows the holder to acquire one common share in the Company
for $0.50 per share. The stock options are valid between a 3 – 5 year period from the date of grant,
were issued in accordance with the Company’s Stock Option Plan and are subject to approval by
regulatory authorities.
The Company’s Stock Option Plan allows for the issuance of up to 10% of issued and outstanding
share capital in the form of incentive stock options. As a result of this grant, the Company has
5,500,000 stock options issued, representing 6% of the issued and outstanding share capital.
